OpGen, Inc. (NASDAQ:OPGN – Get Free Report) shares crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.02 and traded as high as $1.25. OpGen shares last traded at $1.25, with a volume of 962 shares changing hands.
Analyst Upgrades and Downgrades
Separately, StockNews.com assumed coverage on OpGen in a research note on Friday. They set a “sell” rating on the stock.
Check Out Our Latest Report on OpGen
OpGen Stock Performance
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Featured Stories
- Five stocks we like better than OpGen
- Find and Profitably Trade Stocks at 52-Week Lows
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Industrial Products Stocks Investing
- DuPont’s Electronics Spinoff: The Start of Something Big
- How to Invest in Small Cap StocksÂ
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
